Sanofi, KaloBios Pharmaceuticals (KBIO) Granted FDA Fast Track Status for KB001A
Tweet Send to a Friend
Sanofi Pasteur, the vaccines division of Sanofi (NYSE: SNY), and KaloBios Pharmaceuticals (Nasdaq: KBIO) announced today that the U.S. Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE